Bioventus CCO John Nosenzo to retire Oct 1; role not replaced

Bioventus Inc.

John E. Nosenzo, Chief Commercial Officer, to retire effective October 1, 2022.
Company will not replace CCO role; sales management responsibilities transition to three promoted direct reports.
Transition plan agreed on June 27, 2022.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

John E. Nosenzo

Chief Commercial Officer

BVS · Bioventus Inc.

Effective: 2022-10-01
Filed: June 29, 2022, 7:59 PM ET

On June 27, 2022, John E. Nosenzo, Chief Commercial Officer of Bioventus Inc. (the “Company”), and the Company agreed on a transition plan providing for Mr. Nosenzo’s retirement from the Company, effective October 1, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

John E. Nosenzo retired as Chief Commercial Officer at Bioventus Inc..

Action: retired
Role: Chief Commercial Officer

Exact text from the filing

On June 27, 2022, John E. Nosenzo, Chief Commercial Officer of Bioventus Inc. (the “Company”), and the Company agreed on a transition plan providing for Mr. Nosenzo’s retirement from the Company, effective October 1, 2022.

View on SEC.gov

Bioventus Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-185142

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.